ГоловнаArchive of numbers2021Volume 29, issue 4 (109)Autism spectrum disorders and epilepsy: dual diagnosis and therapeutic strategies (literature review)
Title of the article Autism spectrum disorders and epilepsy: dual diagnosis and therapeutic strategies (literature review)
Authors Skrypnyk Tetiana
In the section LITERATURE REVIEW
Year 2021 Issue Volume 29, issue 4 (109) Pages 36-44
Type of article Scientific article Index UDK [616.89-008: 616.853]: 616.31-07 + 616.08 Index BBK -
Abstract

Autism spectrum disorders (ASD) are characterized by significant genetic and clinical polymorphism, comorbidity with neurological and mental disorders. In children with ASD, hotbeds of epileptiform and specific epileptic activity are often registered on the electroencephalogram (EEG), which have a causal relationship with behavioral and emotional disorders. The presence of specific epileptic activity on the EEG, impaired social reciprocity and repetitive behavior may be manifestations of a single pathological process, that results in developmental disorder. The course of ASD can be complicated by epileptic seizures, in particular with the use of neurometabolic drugs. According to the results of some controlled studies, antiepileptic drugs (AED) have shown their effectiveness in the treatment of mental disorders in ASD, including emotional instability, irritability, inhibition of movement. AED which stimulate neurotransmission of γ-aminobutyric acid, are more effective in ASD than blockers of the glutamatergic system. Thymoisoleptic properties of some AED, in particular carbamazepine, valproate acid, lamotrigine in some controlled studies have shown efficacy in the regulation of mood disorders in both children with ASD and children with epilepsy. With the use of carbamazepine, topiramate in children with ASD, there may be impaired attention and cognitive activity; deterioration of attention may be accompanied by increased hyperactivity, impulsivity, motor deceleration. The use of AEDs should be expected to increase the frequency and severity of side effects, including cognitive impairment, motor development, which may lead to impaired general functioning and premature disability, even with seizure control. Specific data on alternative treatments for ASD with seizures such as diet (ketogenic, modified Atkins) are discussed.
Key words autism spectrum disorder, epilepsy, epileptic seizures, antiepileptic drugs (AED)
Access to full text version of the article pdf download
Bibliography
1. Ramaswami G. Genetics of autism spectrum disorder / G. Ramaswami, D. H. Geschwind // Chapter 21 in Handbook of Clinical Neurology. 2018. Vol. 147. P. 321—329. DOI: 10.1016/ b978-0-444-63233-3.00021-x.
2. Autism spectrum disorder / Campisi L., Imran N., Nazeer [et al.] // British Medical Bulletin. 2018. Vol. 127(1). P. 91—100. DOI: https://doi.org/10.1093/bmb/ldy026.
3. Loomes R. What is the male-to-Female ratio in autism spectrum disorder? A systematic review and meta-analysis / Loomes R., Hull L., Mandy W. P. // Child & Adolescent Psychiatry. 2017. Vol. 56(6). P. 466—474. DOI: https://doi.org/10.1016/j. jaac.2017.03.013.
4. Identification of common genetic risk variants for autism spectrum disorder / Grove J., Ripke S., Als T. D. [et al.] // Nature Genetics. 2019. Vol. 51(3), P. 431—444. DOI: https://doi: 10.1038/ s41588-019-0344-8.
5. Sharma S. R. Autism spectrum disorder: Classification, diagnosis and therapy / Sharma S. R., Gonda X., Tarazi, F. I. // Pharmacology & Therapeutics. 2018. Vol. 190. P. 91—104. DOI: https://doi.org/10.1016/j.pharmthera.2018.05.007.
6. The changing epidemiology of autism spectrum disorders / Lyall K., Croen L., Daniels J. [et al.] // Annual Review of Public Health. 2017. Vol. 38(1). P. 81—102. DOI: https://doi. org/10.1146/annurev-publhealth-031816-044318.
7. Prevalence and treatment patterns of autism spectrum disorder in the United States, 2016 / Xu G., Strathearn L., Liu B. [et al.] // JAMA Pediatrics. 2019. Vol. 173(2). P. 153. DOI: https:// doi.org/10.1001/jamapediatrics.2018.4208.
8. Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes / Diaz-Beltran L., Esteban F. J., Varma M. [et al.] // BMC Genomics. 2017. Vol. 18(1). P. 315. DOI: https://doi.org/10.1186/s12864-017-3667-9.
9. Tuchman R. What is the relationship between autism spectrum disorders and epilepsy? / Tuchman R. // Seminars in Pediatric Neurology. 2017. Vol. 24(4). P. 292—300. DOI: https:// doi.org/10.1016/j.spen.2017.10.004.
10. Epileptic encephalopathy and autism: A complex interplay / Chepure A., Somaiya M., Subramanyam A. [et al.] // Journal of Pediatric Neurosciences. 2018. Vol. 13(2). P. 273. DOI: https://doi.org/10.4103/jpn.jpn_172_17.
11. EEG endophenotypes in autism spectrum disorder / Capal J. K., Carosella C., Corbin E. [et al.] // Epilepsy & Behavior. 2018. Vol. 88. P. 341—348. DOI: https://doi.org/10.1016/j. yebeh.2018.09.036. 12. AlKhateeb M. Review in autism and epilepsy / AlKhateeb M. and AlDhalaan H. // Open access peer-reviewed chapter: Epilepsy — Update on Classification, Etiologies, Instrumental Diagnosis and Treatment. 2020. DOI: 10.5772/intechopen.93424. DOI: https://www.intechopen.com/chapters/73193. 13. Besag F. Epilepsy in patients with autism: Links, risks and treatment challenges / Besag F. // Neuropsychiatric Disease and Treatment. 2017. Vol. 14. P. 1—10. DOI: https:// doi.org/10.2147/ndt.s120509.
14. Jacob J. Cortical interneuron dysfunction in epilepsy associated with autism spectrum disorders / Jacob J. // Epilepsy. 2015. Vol. 57(2). P. 182—193. DOI: https://doi.org/10.1111/epi.13272.
15. Prevalence and risk factors for autism spectrum disorder in epilepsy: A systematic review and meta-analysis / Strasser L., Downes M., Kung J. [et al.] // Developmental Medicine & Child Neurology. 2017. Vol. 60(1). P. 19—29. DOI: https://doi.org/10.1111/dmcn.13598.
16. Lee, B. H. Autism spectrum disorder and epilepsy: Disorders with a shared biology / B. H. Lee, T. Smith, A. R. Paciorkowski // Epilepsy & Behavior. 2015. Vol. 47. P. 191—201. DOI: https://doi.org/10.1016/j.yebeh.2015.03.017.
17. Jeste S. S. Autism spectrum disorder and epilepsy / S. S. Jeste, R. Tuchman // Journal of Child Neurology. 2015. Vol. 30 (14). P. 1963—1971. DOI: https://doi. org/10.1177/0883073815601501.
18. Neuropathological mechanisms of seizures in autism spectrum disorder / Frye R. E., Casanova M. F., Fatemi S. H. [et al.] // Frontiers in Neuroscience 2016. Vol.10. P. 192. DOI: https://doi.org/10.3389/fnins.2016.00192.
19. The clinical and genetic features of co-occurring epilepsy and autism spectrum disorder in Chinese children / Long S., Zhou H., Li S. [et al.] // Frontiers in Neurology. 2019. Vol. 10. P. 505. DOI: https://doi.org/10.3389/fneur.2019.00505.
20. Tuchman R. Epilepsy and autism: Neurodevelopmental perspective / R. Tuchman & M. Cuccaro // Current Neurology and Neuroscience Reports. 2011. Vol. 11(4). P. 428—434. DOI: https://doi.org/10.1007/s11910-011-0195-x.
21. The epilepsy–autism spectrum disorder phenotype in the era of molecular genetics and precision therapy / Specchio N., Di Micco V., Trivisano M. [et al.] // Epilepsia. 2021. DOI: https://doi.org/10.1111/epi.17115.
22. Nomi J. S. Face processing in autism spectrum disorders: From brain regions to brain networks / Nomi J. S., Uddin, L. Q. // Neuropsychologia. 2015. Vol. 71. P. 201—216. DOI: https://doi.org/10.1016/j.neuropsychologia.2015.03.029.
23. Quasi‐autistic patterns following severe early global privation / Rutter M., Andersen‐Wood L., Beckett C. [et al.] // Journal of Child Psychology and Psychiatry. 1999. Vol. 40(4) P. 537—549. DOI: https://doi.org/10.1111/1469-7610.00472.
24. Neuro‐epileptic determinants of autism spectrum disorders in tuberous sclerosis complex / Bolton P. F., Park R. J., Higgins, J. N. [et al.] // Brain. 2002. Vol. 125(6). P. 1247—1255. DOI: https://doi.org/10.1093/brain/awf124.
25. Deonna T. Early-onset acquired epileptic aphasia (Landau–Kleffner syndrome, LKS) and regressive autistic disorders with epileptic EEG abnormalities: The continuing debate / T. Deonna, E. Roulet-Perez // Brain and Development. 2010. Vol. 32(9). P. 746—752. DOI: https://doi.org/10.1016/j. braindev.2010.06.011.
26. Association of autism onset, epilepsy, and behavior in a community of adults with autism and severe intellectual disability / Damiani S., Leali P., Nosari G. [et al.] // Brain Sciences. 2020. Vol. 10 (8). P. 486. DOI: https://doi.org/10.3390/ brainsci10080486.
27. Epilepsy and autism severity: A study of 6,975 children / Ewen J. B., Marvin A. R., Law K. [et al.] // Autism Research. 2019. Vol. 12(8). P. 1251—1259. DOI: https://doi.org/10.1002/ aur.2132.
28. Theory of mind and social competence in children and adolescents with genetic generalised epilepsy (GGE): Relationships to epilepsy severity and anti-epileptic drugs // Stewart E., Catroppa C., Gill D. [et al.] // Seizure. 2018. Vol. 60. P. 96—104. DOI: https://doi.org/10.1016/j.seizure.2018.06.015.
29. Wong V. Epilepsy in children with autistic spectrum disorder / V. Wong // Journal of Child Neurology. 1993. Vol. 8(4). P. 316—322. DOI: https://doi.org/10.1177/088307389300800405.
30. Features of autism spectrum disorder (ASD) in childhood epilepsy: A population-based study / Reilly C., Atkinson P., Das K. B. [et al.] // Epilepsy & Behavior. 2015. Vol. 42. P. 86—92. DOI: https://doi.org/10.1016/j.yebeh.2014.11.014.
31. Routine developmental, autism, behavioral, and psychological screening in epilepsy care settings / Eom S., Fisher B., Dezort C. [et al.] // Developmental Medicine & Child Neurology. 2014. Vol. 56(11). P. 1100—1105. DOI: https://doi. org/10.1111/dmcn.12497.
32. Frequent association of autism spectrum disorder in patients with childhood onset epilepsy / Matsuo M., Maeda T., Sasaki K. [et al.] // Brain and Development. 2010. Vol. 32(9). P. 759—763. DOI: https://doi.org/10.1016/j.braindev. 2010.05.005.
33. Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific Manner in the EL mouse / Ruskin D. N., Fortin J. A., Bisnauth S. N. [et al.] // Physiology & Behavior. 2017. Vol. 168. P. 138—145. DOI: https://doi.org/10.1016/j.physbeh.2016.10.023.
34. Kossoff E. H. Ketogenic diets: An update for child neurologists / E. H. Kossoff, B. A. Zupec-Kania, J. M. Rho // Journal of Child Neurology. 2009. Vol. 24(8). P. 979—988. DOI: https://doi.org/10.1177/0883073809337162.
35. Cheng N. Metabolic dysfunction underlying autism spectrum disorder and potential treatment approaches / N. Cheng, J. M. Rho and S. A. Masino // Frontiers in Molecular Neuroscience. 2017. Vol. 10. DOI: https://doi.org/10.3389/ fnmol.2017.00034.
36. Lefevre F. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy / F. Lefevre, N. Aronson // Pediatrics. 2000. Vol. 105(4). P. e46—e46. DOI: https://doi.org/10.1542/peds.105.4.e46.
37. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial / Neal E. G., Chaffe H., Schwartz R. H. [et al.] // The Lancet Neurology. 2008. Vol. 7(6). P. 500—506. DOI: https://doi.org/10.1016/ s1474-4422(08)70092-9.
38. Ketogenic diet and other dietary treatments for epilepsy / Levy R. G., Cooper P. N., Giri P. [et al.] // Cochrane Database of Systematic Reviews. (2012). DOI: https://doi. org/10.1002/14651858.cd001903.pub2.
39. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: A randomized controlled trial / Sharma S., Sankhyan N., Gulati S. [et al.] // Epilepsia. 2013. Vol. 54(3). P. 481—486. DOI: https://doi.org/10.1111/epi.12069.
40. S h a r m a S . K e t o g e n i c d i e t i n e p i l e p t i c Encephalopathies / S. Sharma and M. Tripathi // Epilepsy Research and Treatment. 2013. Vol. 2013. P. 1—5. DOI: https://doi.org/10.1155/2013/652052.
41. Holmes G. L. Drug treatment of epilepsy neuropsychiatric comorbidities in children / G. L. Holmes // Pediatric Drugs. 2020. Vol. 23(1). P. 55—73. DOI: https://doi.org/10.1007/ s40272-020-00428-w.
42. Rüegger A. D. Lacosamide in children with drug-resistant epilepsy / A. D. Rüegger, J. L. Freeman, A. S. Harvey // Journal of Paediatrics and Child Health. 2018. Vol. 55(2). P. 194—198. DOI: https://doi.org/10.1111/jpc.14156.
43. Psychiatric and behavioural disorders in children with epilepsy: An ILAE task force report / Besag F., Aldenkamp A., Caplan R. [et al.] // Epileptic Disorders. 2016. Vol. 18(S1). P. 1—86. DOI: https://doi.org/10.1684/epd.2016.0809.
44. Corrigendum: Characterizing the interplay between autism spectrum disorder and comorbid medical conditions: An integrative review / Tye C., Runicles A., Whitehouse A. J. [et al.] // Frontiers in Psychiatry. 2019. Vol. 10. P. 751 DOI: https://doi.org/10.3389/fpsyt.2019.00438.
45. Association of autism onset, epilepsy, and behavior in a community of adults with autism and severe intellectual disability / Damiani S., Leali P., Nosari G. [et al.] // Brain Sciences. 2020. Vol. 10(8). P. 486. DOI: https://doi.org/10.3390/ brainsci10080486.
46. The genetic landscape of the epileptic encephalopathies of infancy and childhood / McTague A., Howell K. B., Cross J. H. [et al.] // The Lancet Neurology. 2016. Vol. 15(3). P. 304—316. DOI: https://doi.org/10.1016/s1474-4422(15)00250-1.
47. Genetic diagnosis and clinical characteristics by etiological classification in early-onset epileptic encephalopathy with burst suppression pattern / Lee S., Kim S. H., Kim B. [et al.] // Epilepsy Research. 2020. Vol. 163. P. 106323. DOI: https://doi.org/10.1016/j.eplepsyres.2020.106323.
48. Specchio N. Developmental and epileptic encephalopathies: What we do and do not know / N. Specchio, P. Curatolo // Brain. 2020. Vol. 144(1). P. 32—43. DOI: https:// doi.org/10.1093/brain/awaa371.
49. Efektyvnist lamotrydzhynu u ditei ta pidlitkiv z rozladamy povedinky / [Martsenkovskyi I. A., Martsenkovska I. I., Skrypnyk T. O., Makarenko H. V.] // Ukrainskyi medychnyi chasopys. 2020. 4 (138). С. 138. DOI: https://doi. org/10.32471/umj.1680-3051.138.186069.
50. Psychiatric and behavioural disorders in children with epilepsy: An ILAE task force report / Besag F., Aldenkamp A., Caplan R. [et al.] // Epileptic Disorders. 2016. Vol. 18 (S1). P. 1—86. DOI: https://doi.org/10.1684/epd.2016.0809.
51. Anxiety and mood disorder in children with autism spectrum disorder and ADHD / Gordon-Lipkin E., Marvin A. R., Law J. K. [et al.] // Pediatrics. 2018. Vol. 141(4). P. e20171377. DOI: https://doi.org/10.1542/peds.2017-1377.
52. Zaboski B. A. Comorbid autism spectrum disorder and anxiety disorders: A brief review / B. A. Zaboski & E. A. Storch // Future Neurology. 2018. Vol. 13(1). P. 31—37. DOI: https://doi. org/10.2217/fnl-2017-0030.
53. DeFilippis M. Depression in children and adolescents with autism spectrum disorder / M. DeFilippis // Children. 2018. Vol. 5(9). P. 112. DOI: https://doi.org/10.3390/children5090112.
54. Pellock, J. M. Understanding Co-morbidities affecting children with epilepsy / J. M. Pellock, // Neurology. 2004. Vol. 62 (Issue 5, Supplement 2). P. S17—S23. DOI: https://doi. org/10.1212/wnl.62.5_suppl_2.s17.
55. Neuropsychiatric aspects of epilepsy / Tolchin B., Hirsch L. J., LaFrance [et al.] // Psychiatric Clinics of North America. 2020. Vol. 43(2). P. 275—290. DOI: https://doi. org/10.1016/j.psc.2020.02.002.
56. Editorial perspective: COVID‐19 pandemic‐related psychopathology in children and adolescents with mental illness / Jefsen O. H., Rohde C., Norremark, B. [et al.] // Journal of Child Psychology and Psychiatry. 2020. Vol. 62(6). P. 798—800. DOI: https://doi.org/10.1111/jcpp.13292.
57. Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (February/ March 2021): ESCAP CovCAP survey / Revet A., Hebebrand J., Anagnostopoulos D. [et al.] // European Child & Adolescent Psychiatry. 2021. DOI: https://doi.org/10.1007/s00787-021- 01851-1.